Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOSCO: OROS Methylphenidate in Children with ADHD
NCT01012622Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of methylphenidate osmotic release oral system in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Started Sep 2008; status: completed.
02
Drugs
methylphenidate osmotic release oral system
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01012622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012622.